SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019269
Filing Date
2022-05-10
Accepted
2022-05-10 16:07:45
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-10q_20220331.htm   iXBRL 10-Q 2614491
2 EX-31.1 ubx-ex311_6.htm EX-31.1 21398
3 EX-31.2 ubx-ex312_8.htm EX-31.2 21234
4 EX-32.1 ubx-ex321_7.htm EX-32.1 14566
  Complete submission text file 0001564590-22-019269.txt   9169744

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ubx-20220331.xsd EX-101.SCH 66671
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ubx-20220331_cal.xml EX-101.CAL 50060
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ubx-20220331_def.xml EX-101.DEF 231230
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20220331_lab.xml EX-101.LAB 483068
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20220331_pre.xml EX-101.PRE 369404
60 EXTRACTED XBRL INSTANCE DOCUMENT ubx-10q_20220331_htm.xml XML 1654552
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 22909596
SIC: 2834 Pharmaceutical Preparations